Related by context. All words. (Click for frequent words.) 72 GVAX ® 72 HDL Mimetic Peptide 71 Squalamine 71 acetonide FA 71 Vascugel 71 Phase #b/#a clinical 71 CRMD# 70 Trofex 70 immunotherapeutic vaccine 70 Tyrosine Kinase Inhibitor 70 Factor VIIa 70 OvaRex R 70 Vascugel ® 70 BrachySil TM 70 Refractory Angina 70 fosbretabulin 70 Begins Dosing 70 Phase III ADT 69 ONCONASE R 69 DEEP AF 69 Initiates Clinical 69 CINQUIL 69 trastuzumab DM1 T DM1 69 SNS# T 69 Phase IIb clinical trials 69 AFRS TM 69 inhaled AAT 69 Xcytrin R 69 Anavex #-# 69 novel oral anticoagulant 69 Archexin 69 Potelligent Technology 69 NV1FGF 69 MGd 69 Reports Preclinical Data 69 EVIZON TM 69 candidate CRLX# 69 PI3K/Akt pathway inhibitor 69 Personalized Immunotherapy 68 Initiates Phase II 68 Androxal TM 68 hyaluronidase enzyme 68 Zemplar Capsules 68 ELACYT 68 Selective Electrochemical Tumor Ablation 68 Presents Preclinical Data 68 EP #R 68 PRECISE trial 68 TOLAMBA 68 demonstrated antitumor activity 68 CTAP# Capsules 68 candidate TNFerade biologic 68 STRIDE PD 68 Surfaxin LS 68 Initiates Clinical Trial 68 Diabetic Foot Ulcer 68 Adult Stem Cell Therapy 68 pharmacokinetic PK study 68 Completes Patient Enrollment 68 therapeutic monoclonal antibody 68 kidney urologic 68 orally administered inhibitor 68 Degarelix 68 novel therapeutic antibodies 68 Curaxin CBLC# 68 Myoblast 68 QTinno TM 68 PHX# 68 Lixivaptan 68 INS# [001] 68 GVAX R 68 KL4 Surfactant 68 targeted antifolate 68 MGN# 68 Successfully Completes Phase 68 treat chronic sinusitis 68 MAGE A3 ASCI 67 delipidation 67 OHR/AVR# 67 preclinical efficacy 67 CA9 SCAN 67 Immunotherapeutic 67 RECOTHROM R 67 uricase 67 RNAi Therapeutic 67 CCR5 mAb 67 TÎ ² 4 67 Achieves Primary Endpoint 67 forodesine 67 SinuNase ™ 67 indibulin 67 PSMA ADC 67 ARRY # 67 Aflibercept 67 EGS# 67 RNAi therapeutic targeting PCSK9 67 TRX1 67 PFO migraine 67 Panzem R 67 EDEMA3 trial 67 Posiphen TM 67 clevidipine 67 Orqis Medical 67 delivers fluocinolone acetonide FA 67 Fibrin Pad 67 BrachySil ™ 67 successfully commercialize Iluvien 67 Technosphere ® 67 ThermoDox ® clinical 67 preclinical pharmacokinetic 67 investigational humanized monoclonal antibody 67 mGluR2 NAM 67 Nasulin ™ 67 Spiegelmer ® 67 Vascugel R 67 Urocortin 2 67 vidofludimus 67 mTOR inhibition 67 Files IND 67 oral PTH 67 Phase 2b Clinical Trial 67 Hedgehog antagonist 67 Zenvia ™ 67 platform HDL Mimetic 67 novel peptide 67 liposomal formulation 67 Curaxin 67 Abstract Accepted 67 Bezielle 67 coronary stent merged 67 Civacir 67 Hedgehog Pathway Inhibitor 67 MEND CABG II 67 TransVax ™ 67 ALN PCS 67 Oral Calcitonin 67 DermTech International 67 Pyridorin 67 Initiates Enrollment 66 OMNARIS HFA 66 Onconase 66 Tß4 66 oral ghrelin agonist 66 urethral bulking agent 66 targeted radiotherapeutic 66 rxRNA 66 PEG SN# 66 Silodosin 66 candidate deforolimus 66 proprietary PEGylation 66 NPC 1C 66 Phase 2a clinical trials 66 ospemifene 66 Sipuleucel T 66 Phase III HEAT 66 dual endothelin receptor antagonist 66 Adaptive Radiation Therapy 66 mertansine 66 MEND CABG 66 edifoligide E2F Decoy 66 PYY #-# 66 PEGylated interferon 66 CompuFlo 66 orally inhaled migraine 66 Cand5 66 novel histone deacetylase 66 cellular immunotherapy 66 HuMax TAC 66 multicenter Phase II 66 Nonclinical 66 VitiGam 66 pain palliation 66 personalized cellular immunotherapy 66 thetreatment 66 CMV vaccine 66 ImmuKnow R 66 YONDELIS 66 Hsp# Inhibitor 66 Deforolimus 66 Homspera TM 66 Breast Cancer Assay 66 Initiate Clinical Trial 66 catheter occlusion 66 NP2 Enkephalin 66 ENABLE Phase 2 66 G#DT 66 PANVAC VF 66 Vaxfectin R adjuvant 66 CYT# potent vascular disrupting 66 Phase IIb III 66 OvaRex ® MAb 66 apricitabine ATC 66 BrainGate TM 66 Harry Palmin President 66 ZFP Therapeutics 66 M# rationally 66 lucinactant 66 oral beclomethasone dipropionate 66 Novolimus 66 aerosolized KL4 surfactant 66 IL# PE#QQR 66 Neo Bladder Augment 66 CCX# 66 IRX 2 66 HDL Therapy 66 acyclovir Lauriad R 66 potent suppressor 66 ThermoDox R 66 Inosine 66 SNT-MC#/idebenone 66 PrevOnco 66 Presents Preclinical 66 OraTest R 66 ZFP Therapeutic 66 DDP# 66 Generx TM 66 hypoxia activated prodrug 66 MelaFind R 66 Liprotamase 66 initiated Phase Ib 66 Capesaris 66 GMX# 66 EOquin TM 65 Phase III Pivotal 65 ENLIGHT 65 XP #L 65 RhuDex 65 UPLYSO 65 Altastaph 65 Safinamide 65 humanized monoclonal 65 Metastatic Melanoma 65 DCVax R 65 Pimavanserin 65 oral picoplatin 65 rhIGF-I/rhIGFBP-3 65 INTEGRILIN R eptifibatide Injection 65 Phase 2a preventative 65 genomic biomarker 65 Anturol TM 65 Diamyd R 65 Toraymyxin 65 human IgG1 monoclonal 65 oral prodrug 65 next generation URAT1 65 Neo Kidney Augment 65 Meets Primary Endpoint 65 CINTREDEKIN BESUDOTOX 65 PROVENGE ® 65 molecular imaging radiopharmaceutical 65 TBC# 65 NeuroSTAT ® 65 pharmacological chaperone 65 eTag assays 65 PresbyLens ® 65 MOVIPREP R 65 wilate ® 65 Clinical Trial Results 65 Tovaxin TM 65 including eniluracil ADH 65 lexidronam injection 65 Dr. Sosne 65 Ophena TM 65 huC# DM4 65 trial evaluating PRX# 65 Evoltra ® 65 Myocet 65 TNFerade TM 65 LEVADEX ™ 65 IMA# 65 Nanobody R 65 vivo validation 65 Zybrestat 65 Myoblast Program 65 SUTENT ® 65 riociguat 65 Submits Response 65 Demonstrates Sustained 65 SPL# Gel vaginal microbicide 65 ZOLINZA 65 CRLX# 65 Neovasc Reducer 65 depsipeptide 65 Chimigen TM 65 Replacement Therapy 65 ARIKACE ™ 65 ENMD # 65 HuCAL antibodies 65 Solazed TM 65 reslizumab 65 Vernakalant 65 Temsirolimus 65 Phase 1a clinical 65 radiation sensitizer 65 Preclinical Study 65 QLT# 65 Peripheral Arterial 65 factor VIIa 65 Microplasmin 65 Ataluren 65 preclinical pharmacology 65 R roscovitine 65 Pivotal Phase III 65 JAK2 Inhibitor 65 Panzem R NCD 65 novel VDA molecule 65 ALTROPANE 65 INCB# [001] 65 Initiates Phase III 65 hoFH 65 haematological cancers 65 histone deacetylase inhibitor 65 Protexia ® 65 Zysolin TM 65 Virulizin ® 65 Randomized Double blind 65 Chrysalin 65 Bioral Amphotericin B 65 PLK1 SNALP 65 ATIR 65 Duromist ™ 65 Aurora Kinase 65 TRO# 65 null responder 65 antibody MAb 65 Aplidin 65 Hemospan 65 interstitial cystitis IC 65 SPRYCEL ® 65 GAMMAGARD 65 unoprostone isopropyl 65 FOLOTYN ® 65 OncoVEX 65 PDX pralatrexate 65 Announces Poster Presentations 65 Phase 2b Trial 65 novel immunotherapies 65 Ketotransdel 65 small molecule tyrosine 65 DOS# 65 Vaxfectin R 65 Phase III Clinical Trial 65 Extracellular Matrix 65 LB# [003] 65 IMPACT DCM 65 RIGScan CR 65 Tovaxin ® 65 Patients Treated With 65 BioSET 65 MyoCell SDF 1 65 somatostatin analog 65 ExTRACT TIMI 65 Tesetaxel 65 Oral NKTR 65 LEP ETU 65 THR beta agonist 65 optimal dosing regimens 65 Micromet BiTE 65 URG# 65 drug ISA# 65 TransVax 65 Prodarsan R 65 cartilage regeneration 65 SCIB1 65 p# inhibitor 65 Nicholas Borys 65 INSPIRE Trial Phase III 65 Commences Phase 65 evaluating bafetinib 65 Cleviprex TM clevidipine 64 AAG geldanamycin analog 64 Hedgehog agonist 64 abnormal p# 64 phase IIb III 64 PRTX 64 HepaMate 64 NEUVENGE 64 Panzem ® 64 alvespimycin 64 ALN HTT 64 SomatoKine 64 SuperAntibody 64 Alvine Pharmaceuticals 64 NADiA 64 Aeolus Pharmaceuticals Announces 64 oral talactoferrin 64 Liprostin 64 Aviptadil 64 SinuNase TM 64 inhaled liposomal ciprofloxacin 64 ALN VSP Phase 64 Nipent R 64 DiLA2 64 Cx# [002] 64 Bucindolol 64 MIST II 64 cannabinor 64 Exosome 64 Solazed 64 NAVISTAR R 64 somatostatin analogue 64 murine model 64 vernakalant hydrochloride 64 OnDose 64 DXL# 64 LAB CGRP 64 humanised monoclonal antibody 64 MYDICAR 64 LibiGel ® 64 ChronVac C R 64 cathepsin K inhibitor 64 EXPAREL TM 64 please visit www.advaxis.com 64 OMAPRO ™ 64 rhFVIIa 64 NurOwn 64 CARE HF 64 CEQ# 64 Antiangiogenic 64 telomerase therapeutic 64 Tectin TM 64 Antisoma AS# 64 STARFlex R 64 rhITF 64 acadesine 64 Alfacell proprietary ribonuclease 64 Cloretazine ® 64 torezolid phosphate 64 Daclizumab 64 Cerebril TM 64 R#/MEM # 64 alemtuzumab MS 64 echocardiographic parameters 64 relapsed MM 64 gallium containing 64 Initiates Phase 2b 64 metaglidasen 64 dextofisopam 64 sitaxsentan 64 Genz # 64 Sudhir Agrawal D.Phil 64 non nucleoside inhibitor 64 Fabry Disease 64 fibrotic disease 64 targeting CD# 64 Simulect 64 Shows Statistically Significant 64 TACI Ig 64 Demonstrates Significant 64 GRN# 64 GRNVAC1 64 Perforomist ™ Inhalation Solution 64 personalized dendritic 64 rALLy clinical trial 64 EVIZON ™ 64 Hyperparathyroidism 64 Antigen Specific 64 Phase IIB 64 Vaxfectin TM 64 Galectin 3 64 oncolytic virus therapies 64 bazedoxifene conjugated estrogens 64 ATPace TM 64 Completes Enrollment 64 GERD migraine headaches 64 hyperphenylalaninemia HPA due 64 selective inhibition 64 Erimos 64 Neuradiab 64 ZFP Therapeutic TM 64 Prestara 64 STEDESA 64 recurrent glioma 64 isoform selective 64 alagebrium 64 thalidomide Thalomid 64 Pharmacodynamic 64 TransVax tm 64 Multiple Ascending Dose 64 Frozen Shoulder Syndrome 64 Diabetic Neuropathy 64 BioSTAR ® 64 Manja Bouman CEO 64 Phase IIA 64 GLP toxicology studies 64 Octreolin 64 omacetaxine mepesuccinate 64 vinorelbine tartrate 64 vaginally administered lidocaine 64 TKM ApoB 64 Diastolic Heart Failure 64 delivery polymer matrix 64 Accelerated Partial Breast Irradiation 64 StemEx R 64 Belldegrun 64 adult mesenchymal stem 64 Randomized Evaluation 64 Acute Heart Failure 64 Solorel TM 64 adipose derived stem cell 64 DPX Survivac 64 oral anti arrhythmic 64 Clinical Outcome 64 Anticalins R 64 proprietary radiolabeled monoclonal 64 MyVax ® 64 epoetin alpha 64 synthetic retinoid 64 HuCNS SC ® 64 non porcine pancreatic 64 Phase Ib study 64 AERx R 64 PD2i Analyzer 64 Viprinex TM 64 Advanced Heart Failure 64 Georges Gemayel 64 Phase Ib II 64 Trofex TM 64 Cardiotoxicity 64 Inhaled nitric oxide 64 PET tracers 64 HCD# [002] 64 Vitaxin 64 JAK2 inhibitor 64 LEAPS TM 64 Alequel 64 cMET 64 GORE TAG Device 64 Bayer HealthCare Onyx Pharmaceuticals 64 small molecule activators 64 AE# vaccine 64 PROSTVAC VF 64 BioNumerik 64 Dupuytren Disease 64 Genasense ® oblimersen 64 Mipomersen 64 Teriflunomide 64 Presents Positive 64 Kamada AAT 64 VESTASYNC 64 angiotensin analog 64 Canvaxin TM 64 Generx ™ 64 AQUA ® 64 NB S# strontium malonate 64 histamine dihydrochloride 64 EmbraceAC 64 PrevOnco ™ 64 Phase 1b clinical trials 64 treatmentof 64 Fibrin Patch 64 Artelon ® 64 Submits IND 64 Supernus Pharmaceuticals 64 Tolvaptan 64 PERSEUS clinical program 64 anti CD3 monoclonal 64 compound INCB# 64 budesonide foam 64 JAK inhibitor 64 MVA BN R 64 PF # [002] 64 aurora kinase 64 selective modulator 64 Aliskiren 64 molecular chaperone regulation 64 Matrix Phase 2b 64 MediGene focuses 64 Kahalalide F 64 oral renin inhibitor 64 Chemophase 64 Arcelis ™ 64 glucokinase activator 64 PDE4 inhibitor 64 Gets FDA Clearance 64 CIMZIA TM certolizumab pegol 64 Rheos System 64 Pitavastatin 64 CB2 selective receptor agonist 64 CHAMPION PCI 64 DURIN TM 64 tiapamil 64 Nektar proprietary 64 Elagolix 64 AERx iDMS 64 ZK EPO 64 Angiocept 64 Pediatric Oncology Branch 63 mda 7 63 REGEN trial 63 AKT inhibitor 63 Lenocta 63 novel immunotherapeutic 63 EnteroMedics proprietary neuroblocking technology 63 HuMax EGFr 63 Announce Collaboration Agreement 63 Amorcyte 63 phase IIa clinical 63 aerosolized surfactant 63 Bellicum 63 Novel Oral 63 Liposomal 63 Phase Ib Clinical Trial 63 Elocalcitol 63 A3 adenosine receptor 63 Aclidinium 63 KRN# 63 diarrhea predominant irritable 63 Modulates 63 taxane resistant 63 HQK 63 PROSTASCINT R 63 Cathepsin S 63 Vascular Disrupting Agent 63 Bioral 63 NEUGENE R 63 fibrotic disorders 63 recurrent glioblastoma multiforme 63 NeuroHealing 63 Genasense R oblimersen 63 Embolic Protection Device 63 tezampanel NGX# 63 Epigenomics proprietary 63 First Patient Enrolled 63 Symadex 63 Systemic Delivery 63 biostatistical analysis 63 introduced NEUGENE 63 Pafuramidine 63 Fc fusion protein 63 PDE# inhibitors 63 renoprotective 63 cardiac perfusion 63 MYDICAR ® 63 TOCOSOL Camptothecin 63 pharmacodynamic PD 63 Ostabolin C TM 63 Zalypsis 63 P#X# antagonist 63 Receives Orphan Drug Designation 63 Alton Boynton 63 nasal decolonization 63 Adnectin 63 Clinical Validation 63 Corgentin 63 Demonstrates Efficacy 63 CCX# B 63 DUROS 63 treat benign prostatic 63 Metabolic Disease 63 vapreotide acetate 63 Small Molecule 63 Iluvien TM 63 Multimeric 63 Azedra 63 Receives Milestone Payment 63 rhMBL 63 HepDirect prodrug 63 Phase III multicenter 63 CALGB # [002] 63 CCR9 antagonist 63 selective androgen receptor modulator 63 octreotide implant 63 Phase #b/#a 63 VBLOC TM 63 Elafin 63 DCCR 63 atherosclerosis regression 63 Novel Therapeutic 63 oral ridaforolimus 63 investigational monoclonal antibody 63 Pruvel 63 systemic immunosuppressive drugs 63 Darinaparsin 63 BioSTAR R 63 AERx ® 63 Alvesco R 63 ZYBRESTAT TM 63 CORTOSS R 63 intranasal insulin product 63 HepaSphere 63 lomitapide 63 Proellex TM 63 Diamondback #deg 63 Combination REOLYSIN R 63 Teva Provides Update 63 Denufosol 63 trodusquemine 63 Receives Orphan Drug 63 myoblast therapy 63 paclitaxel poliglumex 63 ELND-#/AZD-# 63 TKM PLK1 63 Argatroban 63 Pathway Inhibitor 63 Granted Orphan Drug 63 CVBT #H 63 immatics 63 Allovectin 7 63 BCR ABL inhibitor 63 RhuDex R 63 PORxin TM 63 Tarmogen 63 evaluating mipomersen 63 Phase III ThermoDox 63 intranasal insulin 63 pharmacokinetic PK 63 Fludara ® 63 retinal vein occlusion induced 63 Pivotal Trial 63 Dr. Gorodeski 63 AQ4N 63 omega interferon 63 Activity Assay 63 histone deacetylase HDAC 63 PGL# 63 LHRH receptor positive 63 accumulate preferentially 63 demonstrated clinically meaningful 63 antiangiogenic agent 63 DIFICID ™ 63 MAXY VII 63 Protexia R 63 punctal plug delivery 63 Atopic Dermatitis 63 EXPAREL ™ 63 PNP inhibitor 63 leading oral taxane 63 DMD DMSc 63 dimebon latrepirdine 63 Antibody Discovery 63 Neogenix 63 www.pranabio.com 63 Transcatheter 63 LungAlert TM 63 Biolimus A9 63 proprietary capillary aerosolization 63 Demonstrates Positive 63 LymphoStat B belimumab 63 LPLD 63 AMEX RGN 63 Initiate Phase 63 Aganocide 63 predictive toxicology 63 HDAC Inhibitor 63 metastatic neuroendocrine tumors 63 florbetaben 63 IMC #B 63 Quinamed 63 phase IIb clinical 63 mediated inhibition 63 BAL# [002] 63 SUCCEED trial 63 TELINTRA R 63 purinergic receptors P#X# 63 Thalomid ® 63 Fibrillex TM 63 MacuSight 63 immunotherapeutic approaches 63 GEM OS2 63 punctal plug 63 davunetide intranasal AL 63 Lpathomab 63 mGluR2 positive 63 Bazedoxifene 63 diagnostic radiopharmaceutical 63 ACCLAIM II 63 azilsartan medoxomil 63 HuMax CD#b 63 pharmacokinetic characteristics 63 EECP ® therapy 63 Ad5FGF 4 63 mitogen activated ERK kinase 63 Parathyroid Hormone 63 Locked Nucleic Acid 63 Tomophase 63 Prolongs Survival 63 sunitinib Sutent 63 Marqibo TM 63 eligen 63 Bioral ® 63 OTCBB PWRM.OB 63 Microwave Ablation System 63 Empatic ™ 63 noninvasive outpatient 63 Xanafide 63 Licenses Novel 63 Inhalation Solution 63 immune modulating 63 benign prostatic hypertrophy BPH 63 gastrointestinal motility disorders 63 #beta HSD1 63 Rigel R# 63 CIP TRAMADOL ER 63 receptor tyrosine kinase inhibitor 63 IMiDs ® 63 IMPDH inhibitor 63 small molecule thrombopoietin 63 Altropane 63 motexafin gadolinium Injection 63 toenail onychomycosis 63 urate oxidase 63 gamma secretase inhibitor 63 AcryMed Incorporated 63 OrCel 63 t2cure GmbH 63 Vicriviroc 63 Interferon beta 63 polysaccharide polymer 63 XP# XP# 63 Fibrin MB 63 Bevasiranib 63 tanespimycin 63 Spiegelmer 63 ATL# [002] 63 Andara TM OFS 63 generation URAT1 inhibitor 63 pharmacodynamic markers 63 JenaValve 63 Crofelemer budesonide foam 63 Romidepsin 63 Circulatory Support 63 intracoronary 63 tubulin inhibitor 63 See CLINICAL PHARMACOLOGY 63 MKC# MT 63 Oral Formulation 63 pivotal bioequivalence 63 Ecallantide 63 fusion enhancers 63 PROTECT AF 63 QuadraSphere 63 Modrenal 63 AEG# 63 aplindore 63 Protein Expression 63 Investigational Treatment 63 volociximab 63 pharmacokinetic equivalence 63 Azedra TM 63 EVIZON TM squalamine lactate 63 Cytometry 63 PRESEPT study 63 Altrazeal R 63 ruxolitinib 63 Exelixis compounds 63 Pivotal Phase 63 EVEREST II 63 EchoCRT 63 Tasigna prolongs 63 acute mania 63 anticoagulant reversing agent 63 Tarvacin TM 63 Myolimus 63 Prostate Px + 63 elotuzumab 63 ALN TTR 63 intranasal formulation 63 IV Busulfex 63 Tr DNA 63 Hedgehog inhibitor 63 pharmacodynamic parameters 63 Saforis 63 delafloxacin 63 Microsphere 63 microsphere therapy 63 sulodexide 63 BioGeneriX 63 Inc. PINKSHEETS MEDS 63 Selective Cardiac Myosin Activator 63 Teriparatide 63 beta 1a 63 INOmax R 62 bioengineered tissue 62 AA Amyloidosis 62 SEPET TM 62 MKC# 62 Valtropin 62 Tramiprosate ALZHEMED TM 62 3 registrational trial 62 JAK Inhibitor 62 MGuard ™ 62 Intervention Effectiveness 62 refractory colorectal cancer 62 GOUT 62 Motexafin Gadolinium 62 Trifecta valve 62 Novel Inhibitor 62 Entereg R 62 Phase Ib clinical 62 Telatinib 62 SNT MC# 62 Vascular Wrap TM 62 BZL# 62 incyclinide 62 vitro ADME 62 midstage clinical 62 Dyloject TM 62 Tanespimycin 62 Capsulution 62 Guanilib 62 TASKi3 62 interferon alpha IFN 62 class mGluR5 inhibitor 62 preclinically 62 Ophena 62 atacicept 62 Pivotal Study 62 cerebral oximetry 62 DispersinB R 62 Alocrest 62 recombinant FVIII 62 tolevamer 62 neuronal nicotinic receptor NNR 62 TOCOSOL 62 generation purine nucleoside 62 Plasmin 62 Bafetinib 62 plasmid DNA vaccine 62 Zemiva TM 62 XL# anticancer compounds 62 Vaxfectin ® 62 Fibroblast 62 Clinical Proteomics 62 Dr. Maraganore 62 E2F Decoy 62 Levacor TM 62 Factor 5A 62 Parathyroid hormone 62 BACcel ™ system 62 eprotirome 62 CIPN 62 antimitotic 62 Phase Ib IIa 62 ularitide 62 oral methylnaltrexone 62 Maxy G# 62 reduce serum phosphate 62 PD2i 62 Levulan ® PDT 62 NOD mouse 62 Female Urology 62 engineered anticoagulant 62 essential thrombocythemia ET 62 Efficacy Trial 62 NCIC CTG 62 CIMZIA ™ 62 Unit Dose Budesonide 62 biotherapy 62 endothelin antagonist 62 Septin9 62 FM VP4 62 nalbuphine ER 62 Heterozygous Familial Hypercholesterolemia 62 recurrent metastatic ovarian cancer 62 RhuDex ® 62 recurrent herpes labialis 62 Tumour Vascular Disrupting Agent 62 Pervasis 62 Pertuzumab 62 Shows Promise Against 62 P#Y# [001] 62 overactive bladder syndrome 62 denileukin diftitox 62 undergoing elective percutaneous 62 Urocidin TM 62 ATL# [001] 62 RECOTHROM ® 62 E1 INT TM 62 2 methoxyestradiol 62 GRNCM1 62 allogeneic HSCT 62 nonhuman primate model 62 romazarit 62 TYZEKA 62 R sorafenib tablets 62 Eniluracil 62 RECALL VAX 62 Etubics 62 Recombinant Human 62 HTS assay 62 phase IIb study 62 Diabetic Retinopathy DR 62 topical gel containing 62 ENTEREG ® 62 compound AEZS 62 Tesmilifene 62 Sphingomab TM 62 Aryplase 62 valve implantation 62 antiarrhythmic drug 62 immune modulatory 62 CBLC# 62 P2V TM 62 induced macular edema 62 Ozarelix 62 theranostic 62 candidate REP# 62 Tyrima